National Institutes of Health: Parkinson Disease trials
The registry lists 89 Parkinson Disease studies with National Institutes of Health as lead sponsor. 6 are open to participants now and 6 have results posted.
Early Phase 1 1Phase 1 12Phase 2 24Phase 3 1Phase 4 2No phase 53(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Natural History Protocol for Movement DisordersRecruitingNCT05413291
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain DiseaseRecruitingNCT04396873Phase 1
- Deep Brain Stimulation Therapy in Movement DisordersRecruitingNCT02119611Not applicable
- Deep Brain Stimulation Surgery for Movement DisordersRecruitingNCT01581580Not applicable
- Evaluation and Treatment of Neurosurgical DisordersRecruitingNCT00060541
- Genetic Studies of Lysosomal Storage DisordersEnrolling by invitationNCT00001215
- Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD)CompletedNCT04584346Phase 1Results posted
- Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?TerminatedNCT03104725Phase 1Results posted
- 50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's DiseaseCompletedNCT00977184Phase 1/2Results posted
- Augmenting Effects of L-DOPS With Carbidopa and EntacaponeTerminatedNCT00547911Phase 1/2Results posted
- A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic DysphagiaCompletedNCT00376506Phase 2Results posted
- Transcranial Direct Current Stimulation to Treat Symptoms of Parkinson's DiseaseCompletedNCT00082342Phase 2Results posted
- Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)CompletedNCT04565080
- Attentional Performance in Parkinson DiseaseWithdrawnNCT04428931
- Clinical Laboratory Evaluation of Chronic Autonomic FailureCompletedNCT03648905
- Gait Disorders in Parkinson's DiseaseWithdrawnNCT03416452Early Phase 1
- Clinical and Physiological Studies of Tremor SyndromesCompletedNCT03027310
- Hereditary Parkinson s Disease Natural History ProtocolCompletedNCT02511015
- A Study of Movement Disorders Using the QMAT At-Home Testing DeviceTerminatedNCT01905839
- Imaging Studies of Cognitive Impairment in Parkinson s DiseaseCompletedNCT01862744
- AAV2-GDNF for Advanced Parkinson s DiseaseCompletedNCT01621581Phase 1
- Mutations Associated With Parkinson s DiseaseTerminatedNCT01547832
- Imaging Biomarkers in Parkinson s DiseaseCompletedNCT01496599
- Combined Deep Brain Stimulation for Parkinson's DiseaseWithdrawnNCT01485276Phase 1/2
- Agricultural Health Study Follow-upCompletedNCT01399411
- Genetics of Motor LearningTerminatedNCT01105845
- The Influence of Sensory Stimuli on Gait Imagery in Patients With Freezing of GaitCompletedNCT01071590
- Physiological Investigations of Movement DisordersCompletedNCT01019343Not applicable
- Shanghai Parkinson's StudyCompletedNCT00999388
- Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s DiseaseWithdrawnNCT00921128Phase 1
- Biomarkers of Risk of Parkinson DiseaseCompletedNCT00775853
- P-glycoprotein Function in Brain DiseasesCompletedNCT00677885
- Motor Cortex Reward Signaling in Parkinson DiseaseCompletedNCT00558766
- Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene MutationTerminatedNCT00467090
- Sequence Effect in Parkinson's DiseaseCompletedNCT00431366
- Motor Skill Learning in People With Parkinson's DiseaseCompletedNCT00396942
- Exercise Study For People With Parkinson's DiseaseStatus unknownNCT00387218Not applicable
- Parkinson's Genes and Environment StudyCompletedNCT00367900
- Positron Emission Tomography (PET) Imaging in People With Gaucher MutationsCompletedNCT00302146
- Measures of Motor Impairment in Early Parkinson's DiseaseCompletedNCT00291265
- Talampanel to Treat Parkinson's DiseaseCompletedNCT00108667Phase 2
- Genetic Characterization of Parkinson's DiseaseCompletedNCT00105131
- Relationship of Dopamine to Cognitive Function in Parkinson's DiseaseCompletedNCT00094601
- Lisuride Patch to Treat Parkinson's DiseaseCompletedNCT00089622Phase 2
- Biological Markers in Parkinson's DiseaseCompletedNCT00088335
- ACP-103 to Treat Parkinson's DiseaseCompletedNCT00086294Phase 2
- Levetiracetam Treatment of L-dopa Induced DyskinesiasCompletedNCT00076674Phase 2
- Cell Studies of Parkinson's DiseaseCompletedNCT00076505
- Valerian to Improve Sleep in Patients With Parkinson's DiseaseCompletedNCT00070928Phase 2
- Studying Automatic Movements in Patients With Parkinson's DiseaseCompletedNCT00063661
- Investigating the Safety of srTMS in the Treatment of Parkinson's DiseaseCompletedNCT00063284Phase 1
- Single Photon Emission Computed Tomography to Study Receptors in Parkinson's DiseaseCompletedNCT00058721
- Parkinson's Diseases Susceptibility Genes and PesticidesCompletedNCT00044590
- Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)CompletedNCT00043849Phase 4
- Catechol Thioethers in Parkinson's DiseaseCompletedNCT00042692
- Farming and Movement Evaluation Study (FAME)CompletedNCT00042120
- Molecular Epidemiology of Parkinson's DiseaseCompletedNCT00042107
- JP-1730 to Treat Parkinson's DiseaseCompletedNCT00040209Phase 2
- How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement PerformanceCompletedNCT00040196
- The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's DiseaseCompletedNCT00032812
- Donepezil to Treat Dementia in Parkinson's DiseaseCompletedNCT00030979Phase 4
- Chinese Exercise Modalities in Parkinson's DiseaseCompletedNCT00029809Phase 1/2
- Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's DiseaseCompletedNCT00029666Phase 2
- Magnetic Stimulation for Parkinson DiseaseCompletedNCT00029276Phase 1
- Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's DiseaseCompletedNCT00026598
- PET Scanning in Parkinson s DiseaseCompletedNCT00024622
- Transcranial Magnetic Stimulation in Parkinson's DiseaseCompletedNCT00023062
- Riluzole to Treat Parkinson's DiseaseCompletedNCT00013624Phase 2
- EMD 128130 for the Treatment of Parkinson's DiseaseCompletedNCT00009048Phase 2
- Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's DiseaseCompletedNCT00006488Phase 1
- KW-6002 to Treat Parkinson's DiseaseCompletedNCT00006337Phase 2
- Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's DiseaseCompletedNCT00006077Phase 2
- Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's DiseaseStatus unknownNCT00004844Not applicable
- Timing of Levodopa Treatment in Parkinson's DiseaseCompletedNCT00004733Phase 3
- Parkinson's Disease Treatment With Coenzyme Q10CompletedNCT00004731Phase 2
- Phase II Study of Pallidotomy for Parkinson DiseaseCompletedNCT00004670Phase 2
- Study of LY300164 for the Treatment of Parkinson's DiseaseCompletedNCT00004576Phase 2
- Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease PatientsCompletedNCT00004451Not applicable
- Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's DiseaseCompletedNCT00004387Phase 2
- Treatment of Parkinson's Disease With a Transdermal Skin PatchCompletedNCT00001931Phase 2
- Treatment of Parkinson's Disease With EliprodilCompletedNCT00001929Phase 2
- Intravenous Levodopa for the Diagnosis of Parkinson's DiseaseCompletedNCT00001928
- Effects of Brain Stimulation on Learning and ReasoningCompletedNCT00001776
- Transcranial Magnetic Stimulation for the Treatment of Parkinson's DiseaseCompletedNCT00001665
- Gene Analysis of Parkinson's DiseaseCompletedNCT00001643
- Genetic Analysis of Parkinson's DiseaseCompletedNCT00001640
- Diagnosis and Natural History Study of Patients With Neurological ConditionsCompletedNCT00001549
- Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous SystemCompletedNCT00001365Phase 2
- Studies of Frontal Lobe Brain Functioning in SchizophreniaCompletedNCT00001258